Taylor Devices, Inc. (TAYD) - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended February 28, 2025, and the nine-month period ended on the same date. Taylor Devices, Inc. is a smaller reporting company incorporated in New York, specializing in the design and manufacture of precision components for industrial, structural, and aerospace/defense sectors. The company operates with a fiscal year ending May 31.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Net Revenue | $10.56 million | $12.25 million | $30.73 million | $32.52 million |
| Gross Profit | $4.53 million | $5.75 million | $13.92 million | $14.95 million |
| Gross Margin | 43% | 47% | 45% | 46% |
| Operating Income | $2.02 million | $2.99 million | $5.87 million | $6.97 million |
| Net Income | $2.00 million | $2.70 million | $5.73 million | $6.53 million |
| Diluted EPS | $0.64 | $0.82 | $1.83 | $1.91 |
| Cash & Equivalents | $2.30 million (as of Feb 28, 2025) | |||
| Short-term Investments | $33.14 million (as of Feb 28, 2025) | |||
| Backlog | $33.3 million (as of Feb 28, 2025) |
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased 14% in Q3 and 5% YTD compared to the prior year. This was driven by a 25% drop in aerospace/defense sales and an 8% drop in structural sales, partially offset by a 36% increase in industrial sales.
- Profitability Compression: Gross margin declined to 43% in Q3 (from 47% last year) and 45% YTD (from 46% last year), attributed to lower revenue and shifts in sales mix.
- Geographic Shift: U.S. sales decreased 23% in Q3 and 13% YTD, while international sales (primarily Asia) surged 115% in Q3 and 61% YTD.
- Working Capital: Accounts receivable increased 29% to $6.72 million, causing Days Sales Outstanding (DSO) to rise from 39 to 57 days due to delayed collections on structural projects. Inventory increased 17% to $8.81 million, primarily in work-in-process.
- Accrued Expenses: Accrued expenses rose 71% to $8.0 million, largely due to customer prepayments for a project not yet started.
Outlook, Risks, and Management Commentary
- Backlog: The backlog increased to $33.3 million (146 open orders) from $30.2 million in the prior year. Management expects to recognize the majority of this revenue in fiscal years 2025 and 2026.
- Capital Expenditures: CapEx for the nine months was $1.16 million. The company has commitments for an additional $2.02 million over the next twelve months.
- Liquidity: The company maintains strong liquidity with $35.4 million in cash and short-term investments. There are no long-term debt obligations mentioned in the balance sheet.
- Risks: Key risks include reductions in customer capital budgets, pricing pressures, technological obsolescence of inventory, and the timing of backlog conversion to revenue. The company notes that results for the period are not necessarily indicative of future performance.
- Unusual Items: No material legal proceedings or defaults were reported. Stock-based compensation expense increased significantly YTD ($731k vs $301k prior year) due to option grants.
Investor Verification Checklist
- Verify the collectability of the $6.72 million accounts receivable balance, given the DSO increase to 57 days.
- Monitor the conversion rate of the $33.3 million backlog into revenue, specifically the timing of the 18 projects currently in progress.
- Assess the sustainability of the 61% YTD growth in international sales versus the 13% decline in domestic sales.
- Review the impact of the 4 percentage point gross margin compression on future profitability if the sales mix does not improve.
- Confirm the status of the project generating the $4.9 million in customer deposits (accrued expenses) to ensure revenue recognition timelines align with expectations.